Clinical Trials Directory

Trials / Completed

CompletedNCT06183476

Circadian Amplification in Diabetic Retinopathy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
8 (actual)
Sponsor
University of Illinois at Chicago · Academic / Other
Sex
All
Age
40 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study will test the effects of a 6-week comprehensive circadian optimization intervention Amplify-RHYTHM in patients with diabetic retinopathy. The outcomes of interest are objective and subjective sleep parameters, evening salivary cortisol and melatonin levels, and glucose parameters from continuous glucose monitoring

Detailed description

This study will test the effects of a 6-week comprehensive circadian optimization intervention Amplify-RHYTHM in patients with diabetic retinopathy. The two main components of the intervention are timed light exposure and weekly remote coaching session by psychologist to optimize circadian and sleep behaviors. The outcomes of interest are objective and subjective sleep parameters, evening salivary cortisol and melatonin levels, and glucose parameters from continuous glucose monitoring

Conditions

Interventions

TypeNameDescription
BEHAVIORALAmplify-RHYTHMAmplify-RHYTHM will have two main components: 1) timed light exposure (increase light in the morning, blue light reduction in the evening and eye masks at night), 2) weekly remote coaching session by psychologist to optimize circadian and sleep behaviors

Timeline

Start date
2024-03-20
Primary completion
2025-01-10
Completion
2025-01-10
First posted
2023-12-27
Last updated
2025-08-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06183476. Inclusion in this directory is not an endorsement.